Rarely, more serious side effects can occur, such as persistent or severe abdominal pain (which could be a sign of pancreatitis), or signs of an allergic reaction
Beyond triple agonism, researchers are exploring other combination approaches, including incretin plus amylin agonism or incretin plus FGF21 activation
GENFIT: announces results from interim analysis of RESOLVE-IT phase 3 trial of elafibranor in adults with NASH and fibrosis
Semaglutide and tirzepatide were initially developed to manage type 2 diabetes, but they have shown remarkable effectiveness in supporting weight loss for individuals with obesity
The staffs expertise and exceptional bedside manner are well documented in 5-star reviews
The advisers specifically pointed to the heightened risk of hypoglycemia versus the once-daily Tresiba (insulin degludec) in T1D patients